Found 16 matching trials
A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD) PHASE2 The goal of this study was to evaluate the safety, tolerability and effecti...
Show More Learn More & Join Trial
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma PHASE2 This phase II trial studies how well giving vorinostat, cladribine, and rit...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Learn More & Join Trial
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial NA FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod Learn More & Join Trial
Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia PHASE2 Acute myeloid leukemia (AML) is highly heterogeneous, the efficacy of the i...
Show More Location
Department of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University
Learn More & Join Trial
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab PHASE1 The goal of this clinical research study is to see how well the drugs 2CdA,...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma PHASE2 This study is to explore the efficacy and safety of ChiCGB conditioning the...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL) PHASE2 The researchers are doing this study to compare the safety of vemurafenib i...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
ChiCGB vs BEAM in High-risk or R/R Lymphomas PHASE3 High-dose chemotherapy (HDT) with autologous stem cell transplantation (ASC...
Show More Location
People's Hospital of Deyang City
Learn More & Join Trial
Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
University of Texas - MD Anderson Cancer Center
Learn More & Join Trial